A red-emissive AIE-active cycloiridium(III)-butyltin(IV) heteronuclear complex: Evaluation for A549 cancer cell theranostics
{{output}}
Although cycloiridium(III) complexes and organotin(IV) compounds exhibited potential in anticancer therapy, their commonly observed aggregation-caused quenching (ACQ) effect limited the determination of targeting and anticancer mechanisms. This issue could be ... ...
